Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,339 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Anemia during adjuvant non-taxane chemotherapy for early breast cancer: Incidence and risk factors from two trials of the International Breast Cancer Study Group.
Gianni L, Cole BF, Panzini I, Snyder R, Holmberg SB, Byrne M, Crivellari D, Colleoni M, Aebi S, Simoncini E, Pagani O, Castiglione-Gertsch M, Price KN, Goldhirsch A, Coates AS, Ravaioli A. Gianni L, et al. Among authors: byrne m. Support Care Cancer. 2008 Jan;16(1):67-74. doi: 10.1007/s00520-007-0295-y. Epub 2007 Jul 13. Support Care Cancer. 2008. PMID: 17629752 Free article. Clinical Trial.
Decreased immunoreactivity for p27 protein in patients with early-stage breast carcinoma is correlated with HER-2/neu overexpression and with benefit from one course of perioperative chemotherapy in patients with negative lymph node status: results from International Breast Cancer Study Group Trial V.
Spataro VJ, Litman H, Viale G, Maffini F, Masullo M, Golouh R, Martinez-Tello FJ, Grigolato P, Shilkin KB, Gusterson BA, Castiglione-Gertsch M, Price K, Lindtner J, Cortés-Funes H, Simoncini E, Byrne MJ, Collins J, Gelber RD, Coates AS, Goldhirsch A; International Breast Cancer Study Group. Spataro VJ, et al. Among authors: byrne mj. Cancer. 2003 Apr 1;97(7):1591-600. doi: 10.1002/cncr.11224. Cancer. 2003. PMID: 12655514 Free article.
Phase II trial of ZD0473 as second-line therapy in mesothelioma.
Giaccone G, O'Brien ME, Byrne MJ, Bard M, Kaukel E, Smit B. Giaccone G, et al. Among authors: byrne mj. Eur J Cancer. 2002 Dec;38 Suppl 8:S19-24. doi: 10.1016/s0959-8049(02)80018-1. Eur J Cancer. 2002. PMID: 12647701 Clinical Trial.
Optimizing Mainstreaming of Genetic Testing in Parallel With Ovarian and Endometrial Cancer Tumor Testing: How Do We Maximize Our Impact?
Liu YL, Sia TY, Varice N, Wu M, Byrne M, Khurram A, Kemel Y, Sheehan M, Galle J, Sabbatini P, Brown C, Roche KL, Chi D, Solit DB, Mueller J, Stadler ZK, Hamilton JG, Aghajanian C, Abu-Rustum NR. Liu YL, et al. Among authors: byrne m. JCO Precis Oncol. 2024 Dec;8:e2400525. doi: 10.1200/PO-24-00525. Epub 2024 Dec 23. JCO Precis Oncol. 2024. PMID: 39715484
2,339 results